Abstract
Get full access to this article
View all access options for this article.
References
1.
Haugen
BR
,
Alexander
EK
,
Bible
KC
,
Doherty
GM
,
Mandel
SJ
,
Nikiforov
YE
,
Pacini
F
,
Randolph
GW
,
Sawka
AM
,
Schlumberger
M
,
Schuff
KG
,
Sherman
SI
,
Sosa
JA
,
Steward
DL
,
Tuttle
RM
,
Wartofsky
L
. 2016 . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer . Thyroid , 26 :1 –133 .
2.
Patel
KN
,
Angell
TE
,
Babiarz
J
,
Barth
NM
,
Blevins
T
,
Duh
QY
,
Ghossein
RA
,
Harrell
RM
,
Huang
J
,
Kennedy
GC
,
Kim
SY
,
Kloos
RT
,
LiVolsi
VA
,
Randolph
GW
,
Sadow
PM
,
Shanik
MH
,
Sosa
JA
,
Traweek
ST
,
Walsh
PS
,
Whitney
D
,
Yeh
MW
,
Ladenson
PW
. 2018 . Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules . JAMA Surg , 153 :817 –824 .
3.
Steward
DL
,
Carty
SE
,
Sippel
RS
,
Yang
SP
,
Sosa
JA
,
Sipos
JA
,
Figge
JJ
,
Mandel
S
,
Haugen
BR
,
Burman
KD
,
Baloch
ZW
,
Lloyd
RV
,
Seethala
RR
,
Gooding
WE
,
Chiosea
SI
,
Gomes-Lima
C
,
Ferris
RL
,
Folek
JM
,
Khawaja
RA
,
Kundra
P
,
Loh
KS
,
Marshall
CB
,
Mayson
S
,
McCoy
KL
,
Nga
ME
,
Ngiam
KY
,
Nikiforova
MN
,
Poehls
JL
,
Ringel
MD
,
Yang
H
,
Yip
L
,
Nikiforov
YE
. 2019 . Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: A prospective blinded multicenter study . JAMA Oncol , 5 :204 –212 .
4.
Oh
HS
,
Kwon
H
,
Song
E
,
Jeon
MJ
,
Kim
TY
,
Lee
JH
,
Kim
WB
,
Shong
YK
,
Chung
KW
,
Baek
JH
,
Kim
WG
. 2019 . Tumor volume doubling time in active surveillance of papillary thyroid carcinoma . Thyroid , 29 :642 –649 .
5.
Ito
Y
,
Miyauchi
A
,
Kihara
M
,
Higashiyama
T
,
Kobayashi
K
,
Miya
A
. 2014 . Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation . Thyroid , 24 :27 –34 .
6.
Tuttle
RM
,
Fagin
JA
,
Minkowitz
G
,
Wong
RJ
,
Roman
B
,
Patel
S
,
Untch
B
,
Ganly
I
,
Shaha
AR
,
Shah
JP
,
Pace
M
,
Li
D
,
Bach
A
,
Lin
O
,
Whiting
A
,
Ghossein
R
,
Landa
I
,
Sabra
M
,
Boucai
L
,
Fish
S
,
Morris
LGT
. 2017 . Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance . JAMA Otolaryngol Head Neck Surg , 143 :1015 –1020 .
7.
Livhits
MJ
,
Kuo
EJ
,
Leung
AM
,
Rao
J
,
Levin
M
,
Douek
ML
,
Beckett
KR
,
Zanocco
KA
,
Cheung
DS
,
Gofnung
YA
,
Smooke-Praw
S
,
Yeh
MW
. 2018 . Gene expression classifier vs targeted next-generation sequencing in the management of indeterminate thyroid nodules . J Clin Endocrinol Metab , 103 :2261 –2268 .
8.
Shen
X
,
Zhu
G
,
Liu
R
,
Viola
D
,
Elisei
R
,
Puxeddu
E
,
Fugazzola
L
,
Colombo
C
,
Jarzab
B
,
Czarniecka
A
,
Lam
AK
,
Mian
C
,
Vianello
F
,
Yip
L
,
Riesco-Eizaguirre
G
,
Santisteban
P
,
O'Neill
CJ
,
Sywak
MS
,
Clifton-Bligh
R
,
Bendlova
B
,
Sykorova
V
,
Xing
M
. 2018 . Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer . J Clin Oncol , 36 :438 –445 .
9.
Wang
F
,
Zhao
S
,
Shen
X
,
Zhu
G
,
Liu
R
,
Viola
D
,
Elisei
R
,
Puxeddu
E
,
Fugazzola
L
,
Colombo
C
,
Jarzab
B
,
Czarniecka
A
,
Lam
AK
,
Mian
C
,
Vianello
F
,
Yip
L
,
Riesco-Eizaguirre
G
,
Santisteban
P
,
O'Neill
CJ
,
Sywak
MS
,
Clifton-Bligh
R
,
Bendlova
B
,
Sykorova
V
,
Wang
Y
,
Xing
M
. 2018 . BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer . J Clin Oncol , 36 :2787 –2795 .
10.
Huang
Y
,
Qu
S
,
Zhu
G
,
Wang
F
,
Liu
R
,
Shen
X
,
Viola
D
,
Elisei
R
,
Puxeddu
E
,
Fugazzola
L
,
Colombo
C
,
Jarzab
B
,
Czarniecka
A
,
Lam
AK
,
Mian
C
,
Vianello
F
,
Yip
L
,
Riesco-Eizaguirre
G
,
Santisteban
P
,
O'Neill
CJ
,
Sywak
MS
,
Clifton-Bligh
R
,
Bendlova
B
,
Sykorova
V
,
Xing
M
. 2018 . BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment . J Natl Cancer Inst , 110 :362 –370 .
11.
Kim
HI
,
Kim
TH
,
Choe
JH
,
Kim
JH
,
Kim
JS
,
Kim
YN
,
Kim
H
,
Kim
SW
,
Chung
JH
. 2018 . Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis . Br J Surg , 105 :270 –278 .
12.
Wang
JR
,
Zafereo
ME
,
Dadu
R
,
Ferrarotto
R
,
Busaidy
NL
,
Lu
C
,
Ahmed
S
,
Gule-Monroe
MK
,
Williams
MD
,
Sturgis
EM
,
Goepfert
RP
,
Gross
ND
,
Lai
SY
,
Gunn
GB
,
Phan
J
,
Rosenthal
DI
,
Fuller
CD
,
Morrison
WH
,
Iyer
P
,
Cabanillas
ME
. 2019 . Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAF(V600E)-mutated anaplastic thyroid carcinoma . Thyroid , 29 :1036 –1043 .
13.
Robert
C
,
Grob
JJ
,
Stroyakovskiy
D
,
Karaszewska
B
,
Hauschild
A
,
Levchenko
E
,
Chiarion Sileni
V
,
Schachter
J
,
Garbe
C
,
Bondarenko
I
,
Gogas
H
,
Mandala
M
,
Haanen
J
,
Lebbe
C
,
Mackiewicz
A
,
Rutkowski
P
,
Nathan
PD
,
Ribas
A
,
Davies
MA
,
Flaherty
KT
,
Burgess
P
,
Tan
M
,
Gasal
E
,
Voi
M
,
Schadendorf
D
,
Long
GV
. 2019 . five-year outcomes with dabrafenib plus trametinib in metastatic melanoma . N Engl J Med , 381 :626 –636 .
14.
Guldvog
I
,
Reitsma
LC
,
Johnsen
L
,
Lauzike
A
,
Gibbs
C
,
Carlsen
E
,
Lende
TH
,
Narvestad
JK
,
Omdal
R
,
Kvaloy
JT
,
Hoff
G
,
Bernklev
T
,
Soiland
H
. 2019 . Thyroidectomy versus medical management for euthyroid patients with hashimoto disease and persisting symptoms: A randomized trial . Ann Intern Med , 170 :453 –464 .
15.
Kitahara
CM
,
Berrington de Gonzalez
A
,
Bouville
A
,
Brill
AB
,
Doody
MM
,
Melo
DR
,
Simon
SL
,
Sosa
JA
,
Tulchinsky
M
,
Villoing
D
,
Preston
DL
2019 . Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism . JAMA Intern Med . [Epub ahead of print]; DOI: 10.1001/jamainternmed.2019.0981 .
16.
Okosieme
OE
,
Taylor
PN
,
Evans
C
,
Thayer
D
,
Chai
A
,
Khan
I
,
Draman
MS
,
Tennant
B
,
Geen
J
,
Sayers
A
,
French
R
,
Lazarus
JH
,
Premawardhana
LD
,
Dayan
CM
. 2019 . Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study . Lancet Diabetes Endocrinol , 7 :278 –287 .
17.
Brito
JP
,
Schilz
S
,
Singh Ospina
N
,
Rodriguez-Gutierrez
R
,
Maraka
S
,
Sangaralingham
LR
,
Montori
VM
. 2016 . Antithyroid drugs-the most common treatment for Graves' disease in the United States: A nationwide population-based study . Thyroid , 26 :1144 –1145 .
18.
Anuwong
A
,
Ketwong
K
,
Jitpratoom
P
,
Sasanakietkul
T
,
Duh
QY
. 2018 . Safety and outcomes of the transoral endoscopic thyroidectomy vestibular approach . JAMA Surg , 153 :21 –27 .
19.
Anuwong
A
. 2016 . Transoral endoscopic thyroidectomy vestibular approach: A series of the first 60 human cases . World J Surg , 40 :491 –497 .
20.
White
C
,
Weinstein
MC
,
Fingeret
AL
,
Randolph
GW
,
Miyauchi
A
,
Ito
Y
,
Zhan
T
,
Ali
A
,
Gazelle
GS
, Lubitz CC 2018 Is less more? A microsimulation model comparing cost-effectiveness of the revised American Thyroid Association's 2015 to 2009 Guidelines for the Management of Patients with Thyroid Nodules and Differentiated Thyroid Cancer . Ann Surg [Epub ahead of print]; DOI: 10.1097/SLA.0000000000003074 .
21.
Mazzaferri
EL
. 2006 . Managing small thyroid cancers . JAMA , 295 :2179 –2182 .